Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 68

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 68
---
 NAMED EXPERTS AND COUNSEL</div>

Sichenzia Ross Ference Carmel LLP, New York, New
York, our counsel, was issued 1,667 shares of common stock in the Company’s initial public offering.

<div align='center'>EXPERTS</div>

RBSM LLP, an independent registered public accounting
firm, audited our financial statements for the years ended December 31, 2024 and 2023, respectively. We have included our financial statements
in this prospectus and elsewhere in the registration statement in reliance on the reports of RBSM LLP, given their authority as experts
in accounting and auditing.

<div align='center'>LEGAL MATTERS</div>

Certain legal matters with respect to the validity
of the securities being offered by this prospectus will be passed upon by Sichenzia Ross Ference Carmel LLP, New York, New York. Certain
legal matters in connection with this offering will be passed upon for the placement agent by Troutman Pepper Locke LLP.

<div align='center'>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</div>

The SEC allows us to “incorporate by reference”
information from other documents that we file with it, which means that we can disclose important information to you by referring you
to those documents. The information incorporated by reference is considered to be part of this prospectus. Information in this prospectus
supersedes information incorporated by reference that we filed with the SEC prior to the date of this prospectus. We incorporate by reference
into this prospectus and the registration statement of which this prospectus is a part the information or documents listed below that
we filed with the SEC:

Notwithstanding the statements in the preceding
paragraphs, no document, report or exhibit (or portion of any of the foregoing) or any other information that we have “furnished”
to the SEC pursuant to the Exchange Act shall be incorporated by reference into this prospectus.

We also incorporate by reference into this prospectus
all documents (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are
related to such items) that are filed by us with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (i) after
the date of the initial filing of the registration statement of which this prospectus forms a part and prior to effectiveness of the